Wound-healing studies in transgenic and knockout mice

被引:122
作者
Grose, R
Werner, S
机构
[1] Canc Res UK, London Res Inst Lab 214, London WC2A 3PX, England
[2] Swiss Fed Inst Technol, Inst Cell Biol, Dept Biol, CH-8093 Zurich, Switzerland
关键词
wound healing; mouse; gene targeting; growth factor; cytokine;
D O I
10.1385/MB:28:2:147
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Injury to the skin initiates a cascade of events including inflammation, new, tissue formation, and tissue remodeling, that finally lead to at least partial reconstruction of the original tissue. Historically, animal models of repair have taught us much about how this repair process is orchestrated and, over recent years, the use of genetically modified mice has helped define the roles of many key molecules. Aside from conventional knockout technology, many ingenious approaches have been adopted, allowing researchers to circumvent such problems as embryonic lethality, or to affect gene function in a tissue- or temporal-specific manner. Together, these studies provide us with a growing source of information describing, to date, the in vivo function of nearly 100 proteins in the context of wound repair. This article focuses on the studies in which genetically modified mouse models have helped elucidate the roles that many soluble mediators play during wound repair, encompassing the fibroblast growth factor (FGF) and transforming growth factor-beta (TGF-beta) families and also data on cytokines and chemokines. Finally, we include a table summarizing all of the currently published data in this rapidly growing field. For a regularly updated web archive of studies, we have constructed a Compendium of Published Wound Healing Studies on Genetically Modified Mice which is avaialble at http://icbxs.ethz.ch/members/grose/ woundtransgenic/home.html.
引用
收藏
页码:147 / 166
页数:20
相关论文
共 163 条
  • [1] Augmented inflammatory responses and altered wound healing in cathepsin G-deficient mice
    Abbott, RE
    Corral, CJ
    MacIvor, DM
    Lin, XH
    Ley, TJ
    Mustoe, TA
    [J]. ARCHIVES OF SURGERY, 1998, 133 (09) : 1002 - 1006
  • [2] ABRAHAM LA, 1996, MOL CELLULAR BIOL WO, P195
  • [3] Amendt C, 2002, J CELL SCI, V115, P2189
  • [4] Functions of the POU domain genes Skn-1a/i and Tst-1/Oct-6/SCIP in epidermal differentiation
    Andersen, B
    Weinberg, WC
    Rennekampff, O
    McEvilly, RJ
    Bermingham, JR
    Hooshmand, F
    Vasilyev, V
    Hansbrough, JF
    Pittelkow, MR
    Yuspa, SH
    Rosenfeld, MG
    [J]. GENES & DEVELOPMENT, 1997, 11 (14) : 1873 - 1884
  • [5] Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing
    Ashcroft, GS
    Lei, KJ
    Jin, WW
    Longenecker, G
    Kulkarni, AB
    Greenwell-Wild, T
    Hale-Donze, H
    McGrady, G
    Song, XY
    Wahl, SM
    [J]. NATURE MEDICINE, 2000, 6 (10) : 1147 - 1153
  • [6] Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response
    Ashcroft, GS
    Yang, X
    Glick, AB
    Weinstein, M
    Letterio, JJ
    Mizel, DE
    Anzano, M
    Greenwell-Wild, T
    Wahl, SM
    Deng, CX
    Roberts, AB
    [J]. NATURE CELL BIOLOGY, 1999, 1 (05) : 260 - 266
  • [7] Loss of Smad3 modulates wound healing
    Ashcroft, GS
    Roberts, AB
    [J]. CYTOKINE & GROWTH FACTOR REVIEWS, 2000, 11 (1-2) : 125 - 131
  • [8] The Nf1 tumor suppressor regulates mouse skin wound healing, fibroblast proliferation, and collagen deposited fibroblasts
    Atit, RP
    Crowe, MJ
    Greenhalgh, DG
    Wenstrup, RJ
    Ratner, N
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 112 (06) : 835 - 842
  • [9] CELL-MIGRATION IS ESSENTIAL FOR SUSTAINED GROWTH OF KERATINOCYTE COLONIES - THE ROLES OF TRANSFORMING GROWTH FACTOR-ALPHA AND EPIDERMAL GROWTH-FACTOR
    BARRANDON, Y
    GREEN, H
    [J]. CELL, 1987, 50 (07) : 1131 - 1137
  • [10] Mouse fibroblast growth factor 10: cDNA cloning, protein characterization, and regulation of mRNA expression
    Beer, HD
    Florence, C
    Dammeier, J
    McGuire, L
    Werner, S
    Duan, DR
    [J]. ONCOGENE, 1997, 15 (18) : 2211 - 2218